Drugs Information: Risankizumab

Basic Information

ID DDInter1602
Drug Type biotech
Molecular Formula C6476H9992N1720O2016S44
Molecular Weight -
Description Risankizumab is an interleukin-23 antagonist used to treat moderate to severe plaque psoriasis.
ATC Classification L04AC18
IUPAC Name None
InChI None
InChI Key None
Canonical SMILES None
Useful Links DrugBank

Interactions with Risankizumab

Severity level ID Name Mechanism Detail